K. Py�r�l�
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetes Management and Research
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
- Diabetes Treatment and Management 5
- Diabetes Management and Research 4
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 1
-
- Cardiovascular Function and Risk Factors 5
- Cardiovascular Health and Disease Prevention 1
- Co-authors
- Matti Uusitupa (4 shared papers)Onni Siitonen (2 shared papers)Erkki Voutilainen (3 shared papers)Leo Niskanen (2 shared papers)A. Aro (2 shared papers)Markku Laakso (5 shared papers)H Sarlund (2 shared papers)O Siitonen (1 shared paper)
- Journals
- Diabetologia (9 papers)Advances in cardiology (2 papers)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Documenta Ophthalmologica (1 paper)
- Partner nations
- FinlandUnited StatesUnited Kingdom
In The Last Decade
K. Py�r�l�
12 papers receiving 731 citations
Peers
Comparison fields: 5 of 59
- Endocrinology, Diabetes and Metabolism 340
- Nephrology 82
- Cardiology and Cardiovascular Medicine 226
- Radiology, Nuclear Medicine and Imaging 63
- Surgery 117
Countries citing papers authored by K. Py�r�l�
This map shows the geographic impact of K. Py�r�l�'s research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Py�r�l� with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Py�r�l� more than expected).
Fields of papers citing papers by K. Py�r�l�
This network shows the impact of papers produced by K. Py�r�l�. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Py�r�l�. The network helps show where K. Py�r�l� may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Py�r�l�, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 275 | |
| 2 | 1985 | 143 | |
| 3 | 1990 | 98 | |
| 4 | 1995 | 78 | |
| 5 | 1988 | 65 | |
| 6 | 1995 | 59 | |
| 7 | 1987 | 28 | |
| 8 | 1991 | 8 | |
| 9 | 1992 | 8 | |
| 10 | 1995 | 5 | |
| 11 | 1995 | 5 | |
| 12 | 2015 | 1 | |
| 13 | 2015 | 0 |
About K. Py�r�l�
K. Py�r�l� is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Molecular Biology, Nephrology and Ophthalmology, having authored 13 papers that have together received 773 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Cardiovascular Function and Risk Factors (5 papers), Diabetes Treatment and Management (5 papers), Diabetes Management and Research (4 papers), Metabolism, Diabetes, and Cancer (4 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (1 paper), Cardiovascular Health and Disease Prevention (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (340 citations), Nephrology (82 citations), Cardiology and Cardiovascular Medicine (226 citations), Radiology, Nuclear Medicine and Imaging (63 citations) and Surgery (117 citations). K. Py�r�l� has collaborated with scholars based in Finland, United States and United Kingdom. Frequent co-authors include Matti Uusitupa, Onni Siitonen, Erkki Voutilainen, Leo Niskanen, A. Aro, Markku Laakso, H Sarlund, O Siitonen, Steven M. Haffner and Seppo Lehto. Their work appears in journals such as Diabetologia, Advances in cardiology, European Journal of Nuclear Medicine and Molecular Imaging and Documenta Ophthalmologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.